Terms: = Ovarian cancer AND PDGFRB, JTK12, 5159, P09619, ENSG00000113721, PDGF-R-beta, PDGFR1, CD140B, PDGFR, CD140b AND Diagnosis
6 results:
1. Identification of five serum protein markers for detection of ovarian cancer by antibody arrays.
Jiang W; Huang R; Duan C; Fu L; Xi Y; Yang Y; Yang WM; Yang D; Yang DH; Huang RP
PLoS One; 2013; 8(10):e76795. PubMed ID: 24116163
[TBL] [Abstract] [Full Text] [Related]
2. Endometrial stromal sarcoma arising from endometriosis: a clinicopathological study and literature review.
Lan C; Huang X; Lin S; Cai M; Liu J
Gynecol Obstet Invest; 2012; 74(4):288-97. PubMed ID: 22986788
[TBL] [Abstract] [Full Text] [Related]
3. The PACOVAR-trial: a phase I/II study of pazopanib (GW786034) and cyclophosphamide in patients with platinum-resistant recurrent, pre-treated ovarian cancer.
Eichbaum M; Mayer C; Eickhoff R; Bischofs E; Gebauer G; Fehm T; Lenz F; Fricke HC; Solomayer E; Fersis N; Schmidt M; Wallwiener M; Schneeweiss A; Sohn C
BMC Cancer; 2011 Oct; 11():453. PubMed ID: 22014006
[TBL] [Abstract] [Full Text] [Related]
4. Biomarker expression in pelvic high-grade serous carcinoma: comparison of ovarian and omental sites.
Köbel M; Turbin D; Kalloger SE; Gao D; Huntsman DG; Gilks CB
Int J Gynecol Pathol; 2011 Jul; 30(4):366-71. PubMed ID: 21623201
[TBL] [Abstract] [Full Text] [Related]
5. Female adnexal tumor of probable Wolffian origin (FATWO) with recurrence 3 years postsurgery.
Syriac S; Durie N; Kesterson J; Lele S; Mhawech-Fauceglia P
Int J Gynecol Pathol; 2011 May; 30(3):231-5. PubMed ID: 21464731
[TBL] [Abstract] [Full Text] [Related]
6. Microinvasive cervical adenocarcinoma (FIGO stage 1A tumors): results of surgical staging and outcome analysis.
Ceballos KM; Shaw D; Daya D
Am J Surg Pathol; 2006 Mar; 30(3):370-4. PubMed ID: 16538058
[TBL] [Abstract] [Full Text] [Related]